Tumor Diagnostics

Droplex Assays - A novel solution for targeted therapy selection

Droplex is the diagnostic solution to identify gene mutations in different types of cancer, thereby facilitating clinical decision-making and selection of targeted therapies. By incorporating Droplet DigitalTM PCR technology, Droplex shows improved sensitivity with wider mutation coverage. Contributing to the advancement of precision medicine, the Droplex Test Series provides actionable information to choose the most promising course of treatment that is tailored to individual patients.

BIOTYPE is the exclusive distributor of the Droplex Test Series in Germany. Legal manufacturer of the kits is GENCURIX, Inc.